# Soft Tissue Tumor Classification and Grading

## Overview

Soft tissue tumors encompass a diverse group of mesenchymal neoplasms arising from connective tissues including fat, muscle, fibrous tissue, vessels, and peripheral nerves. The WHO Classification of Tumours of Soft Tissue and Bone (5th edition, 2020) recognizes over 100 histologic types, many now defined by characteristic molecular alterations that serve as both diagnostic and therapeutic targets.

## General Approach to Soft Tissue Tumors

### Clinical Assessment

The clinical context is indispensable in soft tissue tumor diagnosis. Key factors include patient age, anatomic site, depth relative to the investing fascia, tumor size, and growth rate. Superficial tumors (those above the fascia) are far more likely to be benign, while deep tumors warrant higher clinical suspicion for malignancy. The practical "5 cm rule" states that masses greater than 5 cm, deep to fascia, and actively growing warrant aggressive diagnostic workup. MRI imaging is essential before biopsy to characterize the lesion and plan the biopsy tract for potential future resection.

### Morphologic Approach: Pattern-Based Classification

Soft tissue tumors are initially categorized by their dominant microscopic pattern. Spindle cell tumors feature elongated cells with fusiform nuclei arranged in fascicles or sheets. Round cell or small blue cell tumors show uniform small round cells with scant cytoplasm. Pleomorphic tumors exhibit marked nuclear atypia with bizarre cells and variable morphology. Epithelioid tumors contain polygonal cells with ample cytoplasm that can mimic carcinoma. Myxoid tumors feature cells dispersed within a prominent myxoid or mucoid stromal background. This pattern-based approach provides the framework for generating a differential diagnosis and selecting appropriate ancillary studies.

## Spindle Cell Tumors

### Benign

Nodular fasciitis is the most commonly over-diagnosed pseudosarcoma in soft tissue pathology. It is a benign, self-limited myofibroblastic proliferation characterized by a tissue culture-like growth pattern, extravasated red blood cells, and mitotic figures without atypical forms. The defining molecular feature is USP6 rearrangement. Despite its high cellularity and brisk mitotic activity, recognizing the characteristic pattern and short clinical history (usually weeks) prevents unnecessary radical surgery.

Desmoid fibromatosis (aggressive fibromatosis) consists of bland spindle cells arranged in long sweeping fascicles with keloidal collagen. It demonstrates nuclear beta-catenin positivity and harbors CTNNB1 mutations. Though locally aggressive with a tendency for recurrence, it has no metastatic potential and should never be called a sarcoma.

Dermatofibrosarcoma protuberans (DFSP) displays a characteristic storiform or cartwheel pattern, is CD34-positive, and harbors the COL1A1-PDGFB fusion resulting from a t(17;22) translocation. It is classified as intermediate (locally aggressive) because it rarely metastasizes, though fibrosarcomatous transformation can occur and confers metastatic potential. The PDGFB fusion makes DFSP responsive to imatinib therapy.

### Malignant Spindle Cell Tumors

Leiomyosarcoma is characterized by fascicles of eosinophilic spindle cells with distinctive blunt-ended (cigar-shaped) nuclei. It is positive for smooth muscle markers including SMA, desmin, and caldesmon. Common sites include the retroperitoneum, uterus, and large vessels such as the inferior vena cava.

Synovial sarcoma occurs in monophasic (spindle cell only) or biphasic (spindle plus epithelial) forms. Despite its name, it does not arise from synovium. It is defined by the SS18-SSX1/SSX2 fusion resulting from t(X;18). TLE1 is characteristically positive, and focal keratin expression is common -- a feature that can lead to misdiagnosis as carcinoma or mesothelioma. It typically occurs in young adults near joints.

Malignant peripheral nerve sheath tumor (MPNST) is associated with NF1 (neurofibromatosis type 1) in approximately 50% of cases. Morphologically, it shows alternating cellular and myxoid zones. S100 is often focal or lost (unlike its benign counterpart, schwannoma), and SOX10 is variable. Loss of H3K27me3 trimethylation by immunohistochemistry is a helpful diagnostic marker.

Solitary fibrous tumor (SFT) exhibits a "patternless pattern" with staghorn (hemangiopericytoma-like) vessels. It is defined by the NAB2-STAT6 fusion, and STAT6 nuclear positivity by IHC is a highly sensitive and specific diagnostic marker. Most SFTs are benign, but malignant SFT is recognized based on elevated mitotic count, tumor necrosis, and increased cellularity.

## Round Cell / Small Blue Cell Tumors

### Key Entities

Ewing sarcoma presents as sheets of uniform small round blue cells with clear cytoplasm containing glycogen (PAS-positive). Membranous CD99 positivity and nuclear NKX2.2 are characteristic, and the defining molecular feature is an EWSR1 rearrangement, most commonly EWSR1-FLI1 from t(11;22). Though most commonly a bone primary, Ewing sarcoma can also arise in soft tissue.

Rhabdomyosarcoma demonstrates skeletal muscle differentiation. The embryonal subtype (most common in children) shows small round to spindle cells with scattered rhabdomyoblasts and is positive for desmin with often focal myogenin expression. The alveolar subtype shows round cells arranged in alveolar spaces separated by fibrous septa, with diffuse strong myogenin positivity and PAX3-FOXO1 or PAX7-FOXO1 fusion conferring worse prognosis. The pleomorphic subtype occurs in adults with bizarre cells expressing skeletal muscle markers.

Desmoplastic small round cell tumor typically affects young males with peritoneal involvement. It is defined by the EWSR1-WT1 fusion from t(11;22) and characteristically co-expresses epithelial (keratin), mesenchymal (desmin in a dot-like pattern), and neural markers, with WT1 C-terminus positivity.

CIC-rearranged sarcoma shows round cell morphology similar to Ewing sarcoma but has variable CD99 expression. ETV4 is characteristically positive, and the defining CIC-DUX4 fusion distinguishes it from Ewing sarcoma. It behaves more aggressively than classical Ewing sarcoma.

## Adipocytic Tumors

### Benign

Lipoma, composed of mature adipocytes without atypia, is the most common soft tissue tumor overall. Spindle cell/pleomorphic lipoma characteristically arises in the posterior neck and shoulder region, is CD34-positive with Rb loss, and contains mature fat with spindle cells and occasional floret giant cells. Hibernoma shows brown fat differentiation with granular eosinophilic multivacuolated cytoplasm.

### Intermediate and Malignant

Atypical lipomatous tumor (ALT) and well-differentiated liposarcoma (WDLPS) represent the same biological entity. The term ALT is used for extremity locations where surgical cure by complete excision is straightforward, while WDLPS is used for retroperitoneal tumors where recurrence is common due to anatomic constraints. Both are defined by MDM2 and CDK4 amplification on ring or giant marker chromosomes. Histologically, they show variation in adipocyte size, fibrous septa, and scattered atypical hyperchromatic stromal cells. MDM2 immunohistochemistry and/or FISH is the gold standard for confirming this diagnosis and distinguishing it from benign lipoma.

Dedifferentiated liposarcoma shows an abrupt transition from a well-differentiated lipogenic component to a high-grade non-lipogenic sarcoma. MDM2/CDK4 amplification is retained in both components. This tumor is aggressive with potential for distant metastasis.

Myxoid liposarcoma features prominent myxoid stroma with a distinctive delicate plexiform ("chicken-wire") vascular pattern and scattered lipoblasts at various stages of differentiation. It is defined by DDIT3 rearrangement, most commonly FUS-DDIT3 from t(12;16). The presence of round cell areas exceeding 5% of the tumor indicates higher grade and worse prognosis.

Pleomorphic liposarcoma is a high-grade pleomorphic sarcoma containing lipoblasts but lacking MDM2 amplification. It carries the worst prognosis among liposarcoma subtypes.

## Vascular Tumors

Hemangiomas are benign vascular proliferations with many subtypes (capillary, cavernous, epithelioid). Epithelioid hemangioendothelioma (EHE) is of intermediate malignancy, showing cords and strands of epithelioid endothelial cells in a myxohyaline stroma, defined by WWTR1-CAMTA1 fusion and positive for ERG and CD31. Angiosarcoma is a malignant vascular tumor featuring irregular anastomosing vascular channels that infiltrate tissue. It is positive for ERG and CD31, with variable CD34 expression, and FLT4 positivity in secondary lymphedema-associated cases.

## Tumors of Uncertain Differentiation

Epithelioid sarcoma occurs in classic (distal extremity, young adults) and proximal types. The hallmark is loss of INI1 (SMARCB1) expression by immunohistochemistry. It is characteristically keratin-positive and EMA-positive with variable CD34 expression, which can lead to confusion with carcinoma or granulomatous inflammation.

Alveolar soft part sarcoma (ASPS) displays an organoid/alveolar pattern with cells containing granular PAS-positive diastase-resistant crystals. Nuclear TFE3 positivity reflects the defining ASPSCR1-TFE3 fusion. Despite slow growth, it frequently metastasizes to lungs and brain.

Clear cell sarcoma is sometimes called the "melanoma of soft parts" because it expresses melanocytic markers (S100, HMB-45, Melan-A) but arises in tendons and aponeuroses rather than skin. It is defined by the EWSR1-ATF1 fusion and, critically, lacks BRAF mutations, which distinguishes it from metastatic melanoma.

## Grading

### FNCLCC (French Federation of Cancer Centers) Grading System

The FNCLCC system is the standard grading system for soft tissue sarcomas. It scores three parameters: differentiation (1-3, based on how closely the tumor resembles normal tissue), mitotic count per 10 high-power fields (1: 0-9, 2: 10-19, 3: 20 or more), and tumor necrosis (0: none, 1: less than 50%, 2: 50% or more). The scores are summed for a total of 2-8 points. Grade 1 (low) corresponds to a total score of 2-3, Grade 2 (intermediate) to 4-5, and Grade 3 (high) to 6-8.

| Parameter | Score 1 | Score 2 | Score 3 |
|---|---|---|---|
| Differentiation | Closely resembles normal tissue | Definite histologic typing | Undifferentiated / uncertain type |
| Mitotic count (per 10 HPF) | 0–9 | 10–19 | ≥20 |
| Tumor necrosis | None (0 points) | <50% (1 point) | ≥50% (2 points) |

| Total Score | FNCLCC Grade |
|---|---|
| 2–3 | Grade 1 (low) |
| 4–5 | Grade 2 (intermediate) |
| 6–8 | Grade 3 (high) |

### Limitations of Grading

Some tumor types behave aggressively regardless of their histologic grade -- synovial sarcoma, MPNST, and epithelioid sarcoma are treated as high-grade tumors irrespective of FNCLCC score. The grading system does not apply to all sarcoma types; GIST, for instance, uses its own risk stratification based on mitotic rate, tumor size, and anatomic site. Increasingly, molecular subtype is more predictive of behavior than histologic grade alone.

## Molecular Diagnostics in Soft Tissue Tumors

### Characteristic Translocations

Many soft tissue tumors are defined by recurrent chromosomal translocations producing fusion oncogenes. Key examples include EWSR1-FLI1 in Ewing sarcoma from t(11;22), SS18-SSX1/2/4 in synovial sarcoma from t(X;18), FUS-DDIT3 in myxoid liposarcoma from t(12;16), COL1A1-PDGFB in DFSP from t(17;22), PAX3-FOXO1 in alveolar rhabdomyosarcoma from t(2;13), EWSR1-ATF1 in clear cell sarcoma from t(12;22), EWSR1-WT1 in desmoplastic small round cell tumor from t(11;22), FUS-CREB3L2 in low-grade fibromyxoid sarcoma from t(7;16), and ALK rearrangement at 2p23 in inflammatory myofibroblastic tumor.

| Tumor | Fusion Gene | Translocation |
|---|---|---|
| Ewing sarcoma | EWSR1-FLI1 | t(11;22) |
| Synovial sarcoma | SS18-SSX1/2/4 | t(X;18) |
| Myxoid liposarcoma | FUS-DDIT3 | t(12;16) |
| DFSP | COL1A1-PDGFB | t(17;22) |
| Alveolar rhabdomyosarcoma | PAX3-FOXO1 | t(2;13) |
| Clear cell sarcoma | EWSR1-ATF1 | t(12;22) |
| Desmoplastic small round cell tumor | EWSR1-WT1 | t(11;22) |
| Low-grade fibromyxoid sarcoma | FUS-CREB3L2 | t(7;16) |
| Inflammatory myofibroblastic tumor | ALK rearrangement | 2p23 |

### Testing Methods

FISH using break-apart probes detects common rearrangements rapidly and is widely available, though it is limited to known targets. RT-PCR offers specific fusion detection with fast turnaround but requires knowledge of the fusion partners involved. Next-generation sequencing with RNA sequencing provides comprehensive fusion detection including novel partners and is becoming the standard for sarcoma diagnosis. IHC surrogates offer practical screening: STAT6 for SFT, INI1 loss for epithelioid sarcoma, TLE1 for synovial sarcoma, and MDM2/CDK4 for well-differentiated liposarcoma.

<image>A medical illustration showing the histologic patterns of five major categories of soft tissue tumors with representative H&E microscopic appearances. Panel A: Spindle cell pattern (leiomyosarcoma) with intersecting fascicles of elongated eosinophilic cells with cigar-shaped nuclei. Panel B: Round cell pattern (Ewing sarcoma) with sheets of uniform small blue cells with clear cytoplasm and round nuclei. Panel C: Pleomorphic pattern (undifferentiated pleomorphic sarcoma) with bizarre multinucleated giant cells and marked nuclear atypia. Panel D: Myxoid pattern (myxoid liposarcoma) with scattered stellate cells in abundant pale blue myxoid stroma with a delicate chicken-wire capillary network. Panel E: Epithelioid pattern (epithelioid sarcoma) with nests of polygonal cells with ample eosinophilic cytoplasm, resembling carcinoma or granuloma.</image>

<image>A medical illustration comparing the key morphologic and immunohistochemical features used to distinguish ALT/WDLPS from a benign lipoma. The left panel shows a lipoma with uniform mature adipocytes of similar size and no atypical stromal cells. The right panel shows an ALT/WDLPS with variation in adipocyte size, thick fibrous septa containing enlarged hyperchromatic atypical stromal cells (with arrows pointing to these cells), and a lipoblast with a scalloped nucleus indented by a cytoplasmic lipid vacuole. Below each panel, IHC results are shown: MDM2 negative in lipoma versus strong nuclear MDM2 positivity in the atypical stromal cells of ALT/WDLPS. A FISH panel shows MDM2 amplification (multiple red signals per green centromeric signal) in ALT/WDLPS.</image>

## Clinical Pearls

Nodular fasciitis is the most commonly over-diagnosed "sarcoma" and is actually a benign, self-limited process with USP6 rearrangement; recognizing the tissue culture-like pattern and short clinical history prevents unnecessary radical surgery. When encountering a pleomorphic spindle cell tumor in an adult, consider undifferentiated pleomorphic sarcoma as a diagnosis of exclusion only after ruling out sarcomatoid carcinoma, melanoma, and dedifferentiated liposarcoma with MDM2 testing. MDM2 FISH or IHC should be performed on any retroperitoneal adipocytic tumor because the distinction between lipoma and ALT/WDLPS is critical for surgical planning and follow-up. Synovial sarcoma can be monophasic and express keratins, mimicking carcinoma or mesothelioma, so TLE1 immunohistochemistry and SS18 FISH are essential for correct classification. INI1 (SMARCB1) loss is characteristic of epithelioid sarcoma but also occurs in rhabdoid tumors, some renal medullary carcinomas, and atypical teratoid/rhabdoid tumors of the CNS. In the era of targeted therapy -- imatinib for DFSP, larotrectinib for NTRK-fused sarcomas, and crizotinib for ALK-rearranged inflammatory myofibroblastic tumor -- molecular characterization has direct therapeutic implications beyond diagnosis. Grade is prognostically important, but tumor type often supersedes grade in predicting biological behavior, and both should always be provided in the pathology report.

## References
- WHO Classification of Tumours Editorial Board. *Soft Tissue and Bone Tumours*. WHO Classification of Tumours, 5th ed, Volume 3. IARC; 2020.
- Goldblum JR, Weiss SW, Folpe AL. *Enzinger and Weiss's Soft Tissue Tumors*. 7th ed. Elsevier; 2020.
- Guillou L, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. *J Clin Oncol*. 1997;15(1):350-362.
- Doyle LA. Sarcoma classification: An update based on the 2013 WHO Classification of Tumors of Soft Tissue and Bone. *Cancer*. 2014;120(12):1763-1774.
- Baranov E, Bhattacharjee M. Soft tissue special issue: Fibroblastic and myofibroblastic neoplasms of the head and neck. *Head Neck Pathol*. 2020;14:43-58.